Background and Purpose-Data on the incidence and outcomes of acute myocardial infarction (AMI) complicating acute ischemic stroke (AIS) are limited. We aim to evaluate the incidence, treatment patterns, and outcomes of AMI in patients with AIS using a nationwide database. Methods-The National Inpatient Sample was used to identify patient with AIS between 2003 and 2014. Trends of incidence of AMI and its associated in-hospital mortality were evaluated. Univariate and multivariate logistic regressions were used to evaluate predictors of AMI. The impact of AMI on in-hospital outcomes was assessed in a comparative analysis of propensity-matched groups of patients with and without AMI. Results-Patients with AIS (n=864 043) were identified in the national inpatient sample, of whom 13 573 patients (1.6%) had an AMI (79.5% non-ST-segment-elevation myocardial infarction and 20.5% ST-segment-elevation myocardial infarction). In-hospital mortality was 21.4% and 7.1% in propensity-matched cohorts of patients with and without AMI, P<0.001. In-hospital length of stay and cost of care were 50% higher in the AMI group. In a multivariate logistical regression analysis, the strongest predictors of having AMI after AIS were older age, history of coronary artery disease, chronic renal insufficiency, undergoing mechanical thrombectomy, and rhythm and conduction abnormalities. In the AMI group, undergoing coronary angiography and undergoing percutaneous coronary intervention both strongly correlated with lower in-hospital mortality (odds ratio, 0. 
S
troke is a leading cause of mortality and serious long-term disability worldwide. 1, 2 In-hospital death accounts for 40% of stroke-related mortality. 3 Cardiac complications are implicated in a large percentage of early death after intracranial hemorrhage, but their association with in-hospital mortality after acute ischemic stroke (AIS) is less well studied. [4] [5] [6] [7] [8] Also, large-scale data on the management of acute myocardial infarction (AMI) after AIS remain limited. We aim to use the national inpatient sample (NIS) to assess (1) the national trends of AMI after AIS between 2003 and 2014, (2) patterns of care and predictors of undergoing ischemic evaluation for AMI complicating AIS, (3) the impact of post-AIS-AMI on in-hospital mortality, length of stay, and cost of care, and (4) potential predictors of adverse outcomes in patients with AIS and AMI.
Methods

Study Data
The NIS was used to derive patient relevant information between January 2003 and December 2014. The NIS is the largest publicly available all-payer administrative claims-based database and contains information about patient discharges from ≈1000 nonfederal hospitals in 45 states. It contains clinical and resource utilization information on 5 to 8 million discharges annually, with safeguards to protect the privacy of individual patients, physicians, and hospitals. These data are stratified to represent ≈20% of US inpatient hospitalizations across different hospital and geographic regions (random sample). National estimates of the entire US hospitalized population were calculated using the Agency for Healthcare Research and Quality sampling and weighting method. The NIS database is a deidentified national database. Therefore, individual patient's consent and institutional board review were waived. The Healthcare Research and Quality data use agreement course was completed, and a user agreement code was obtained.
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Study Population
Patients >18-year-old with a principle admission diagnosis of AIS ( Table I in the online-only Data Supplement.
Outcomes Analysis and Study End Points:
We assessed the temporal trends of the incidence of AMI after AIS. Patients were divided into those 2 groups: AIS with AMI and AIS without AMI. To account for potential confounding factors and reduce the effect of selection bias, a propensity score-matching model was developed using logistic regression to derive 2 matched groups for comparative outcomes analysis. Patients admitted with AIS with or without a subsequent AMI were entered into a nearest neighbor 1:1 variable ratio, parallel, balanced propensity-matching model using a caliper of 0.01 without replacement to ensure perfect matching. Variables included in the propensity match model are listed in Table II in the online-only Data Supplement. A comparative analysis was then conducted between the 2 groups with a primary end point of in-hospital mortality and a secondary end point of cost and resource utilization. To estimate the cost of hospitalization, the NIS data were merged with cost-to-charge ratios available from the Healthcare Cost and Utilization Project. We estimated the cost of each inpatient stay by multiplying the total hospital charge with cost-to-charge ratios. Predictors of AMI after AIS, predictors of undergoing an invasive ischemic evaluation after AMI, and predictors of in-hospital mortality in patients with AMI were assessed. Figure I in the online-only Data Supplement). The incidence of reported AMI after AIS increased during the study period (P trend <0.001; Figure 1) Outcomes in the unmatched Cohorts: in-hospital mortality was significantly higher in the AMI group (21.4% versus 4.4%; P<0.001). Also, rates of major morbidities were higher in the AMI group (Table 2) . Patients in the AMI group were less likely to be discharged home, had longer hospital stays, and had higher cost of hospitalization. 
Statistical Analysis
Outcomes in the Propensity-Matched Cohorts
After propensity score matching, baseline characteristics were well matched between the 2 groups as shown in Table 1 . Variables used in propensity score matching are listed in Table  I in the online-only Data Supplement. In-hospital mortality remained significantly higher in the AMI group (21.4% versus 7.1%; P<0.001). In addition, rates of major morbidities including vascular complications, acute kidney injury, intracranial hemorrhage, mechanical ventilation, and blood transfusion were significantly higher in the AMI group (Table 2) . Patients with AMI had a longer hospital length of stay and had 50% higher in-hospital cost of care compared with those without AMI. In addition, they were much less likely to be discharged home versus discharged to institutionalized care compared with patients without AMI (22.1% versus 38.4%; P<0.001). Temporal trends in in-hospital mortality, length of stay, cost, and nonroutine discharges are presented in Figure 2 . Among the 13 573 patients with AMI, only 1012 (7.5%) underwent coronary angiography, and 270 (2%) underwent percutaneous coronary intervention (PCI). Interestingly, in the AMI group, only 1476 patients (10.9%) had an echocardiogram done during the hospitalization (Table 3) . Although STEMI patients had higher occurrence of cardiac arrest and cardiogenic shock, they were less likely to undergo coronary angiography ( Table 3 ).
We found a significant correlation between undergoing cardiac catheterization and improved in-hospital mortality in patients with AMI (unadjusted OR, 0.43; CI, 0.28-0.64; adjusted OR, 0.34; CI, 0.23-0.51; P<0.001). Similar correlation was found between undergoing PCI and lower inhospital mortality in these patients (unadjusted OR, 0.22; CI, 0.17-0.29; adjusted OR, 0.26; CI, 0.20-0.34; P<0.001; Table 4 ).
Discussion
The principle findings of the current investigations are (1) AMI complicated 1.6% of AIS in the United States with a slight upward trend in the reported incidence over the last 12 years. (2) Older age was the strongest predictor of AMI after AIS. Previous coronary artery disease, chronic renal disease, atrial fibrillation, conduction abnormalities, and undergoing mechanical thrombectomy were also predictive of post-AIS AMI. (3) AMI after AIS is associated with a 3-fold increase of in-hospital mortality and a 50% increase in length of hospitalization and cost of case. (4) A minority (<10%) of patients with AMI after AIS undergoes ischemic evaluation. However, we identified a possible correlation between coronary angiography±coronary interventions and improved inhospital mortality in patients with AMI and AIS.
AMI is a potentially life-threatening complication in patients admitted with AIS. Albeit uncommon, this entity continues to pose a diagnostic and therapeutic dilemma for the treating physicians because of uncertainties surrounding the optimal management strategy and the lack of societal or consensus guidelines. 12 At the pathophysiological level, AMI after AIS can be because of 2 major plausible causes in this patient's cohort that is characterized with high prevalence of coronary artery disease and its risk factors: (1) incidental development of thrombotic occlusion of a coronary vessel (Type I MI); (2) exacerbation of underlying coronary artery disease or interval development of stress-induced myocardial injury or stunning because of the autonomic deregulation and catecholamine surge associated with AIS (type II MI). 13 Our study, although unable to identify specific underlying causes, does confirm previous reports suggesting a low but increasing incidence of AMI in patients with AIS, mainly driven by an increase in the reported incidence of NSTEMI.
14 This increasing incidence, however, can be related to both the increasing sensitivity of the available diagnostic laboratory tests for MI (high-sensitivity troponin I or high-sensitivity troponin T) and the increasing utilization of these tests in patients admitted with AIS.
Our findings reveal that despite the declining mortality of patients with AIS in the last decade, cardiac complications of AIS continue to have a substantial negative impact on shortterm survival and resource utilization. In our study, about 1 in 5 patients who develop AMI after AIS died in the hospital, a mortality rate that is 3-fold higher than propensity-matched group of AIS patients without AMI. In addition, AMI led to 50% increase in length of stay and cost of hospitalization despite the low rates of revascularization. Therefore, further research is needed to identify preventative and therapeutic strategies that aim to lower the very high mortality in patients with AIS and AMI.
Our assessment of the national practice in the management of patients with AMI after AIS reveals several intriguing findings: only a minority of patients with AMI underwent invasive cardiac testing (7.5% underwent coronary angiography and 2% underwent PCI). This can be because of several possible reasons: (1) the belief that most AMI after AIS are type II MIs and that invasive cardiac testing might not be necessary in the acute setting; (2) the hesitation to subject patients with AIS to cardiac catheterization because of the fear of hemorrhagic conversion secondary to 
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anticoagulant or antiplatelet agents use, particularly if systemic thrombolytic were administered. However, we did not observe higher rates of hemorrhagic conversion in patients with AMI who underwent coronary angiography±PCI compared with those who did not; (3) the lack of data supporting the advantage of an invasive strategy in these patients. Nevertheless, we also found a low rate of echocardiography utilization (10.9%) of all patients with AMI, suggesting a national preference of conservative management of these patients overall. The use of echocardiography in patients with AIS has been associated with better odds of survival; a study by Papolos et al 15 suggested a 64% mortality reduction with the utilization of echocardiography in patients with stroke (adjusted OR, 0.36; CI, 0.31-0.42; P<0.001). Interestingly, we found a similar association between invasive cardiac testing±intervention with a lower overall mortality in the AMI cohort (adjusted OR, 0.34; CI, 0.23-0.51; P<0.001) for cardiac catheterization and (adjusted OR 0.26: CI 0.20-0.34; P<0.001) for PCI. Although this finding can be confounded by the tendency to select more well patients for invasive testing/treatment, it does raise the question that we may perhaps be missing an opportunity to improve outcomes in these patients by avoiding adequate invasive assessment and treatment.
Limitations
This study has many limitations. (1) The NIS is an administrative database that gathers data for billing purposes and can be limited by erroneous coding. However, we utilized ICD-9-CM codes for AIS and its complications that have been associated with high specificity and positive predictive value in our analysis. 9, 10 The NIS database is also subject to vigorous quality control measures that should minimize these possibilities. Furthermore, the hard clinical end points used in our analysis (in-hospital mortality) are difficult to miscode. (2) We used the principle discharge diagnosis to identify patients who presented with AIS in the NIS database. Because only 1 principle diagnosis is allowed in administrative database, it is not possible to identify patients who presented with simultaneous AMI and AIS. Nevertheless, we think that simultaneous AMI and AIS are uncommon and given the very large sample size, this limitation is unlikely to impact the study's outcomes. (3) NIS allows detailed assessment of in-hospital outcomes. However, baseline and postprocedural laboratory and brain imaging data are not captured. Also, data needed to calculate traditional stroke severity scale numbers are not available in NIS. Therefore, a selection bias of patients with AIS for cardiac interventions and for mechanical thrombectomy cannot be fully excluded. (4) Information about hemorrhagic transformation of AIS are obtained from ICD-9 codes. NIS does not contain imaging data or National Institutes of Health Stroke Scale scores, and therefore milder or nonsymptomatic hemorrhagic transformations may have been missed in this data set. (5) The potential for unmeasured confounders may bias the outcomes results. However, we think that our rigorous propensity matching has adequately addressed this selection bias.
Conclusions
AMI complicating ischemic stroke is uncommon but is associated with 3-fold increase in mortality and 50% increase in hospital length of stay and cost of care. Invasive evaluation±treatment may lead to improved survival in patients with AMI after AIS; however, it is only utilized in <10% of them. Further studies are needed to identify possible underlying causes and ideal management approaches of AMI in patients with AIS.
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